HGG advances · 2025
Colon cancer in Appalachian Kentucky: Unique genetic, microbiome and obesity findings in a cohort comparison.
СтатьяСравнительное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chow Zeta, Liu Jinpeng, He Daheng, Wang Chi, Gan Tong, Mansour Akila, Shaker Nuha, Dravillas Caroline, Hoyd Rebecca, Durbin Eric, Napier Dana, Gao Tianyan, Schaberg Kurt, Huang Lyen, Ulrich Neli, Siegel Erin, Edge Stephen, Cook Linda, Salhia Bodour, Churchman Michelle, Kolesar Jill, Spakowicz Daniel, Evers B Mark, Bocklage Therese
Аннотация
We investigated colon cancer genomics and microenvironmental features in the Appalachian Kentucky population, a group with the highest incidence of colon cancer in the United States. We assessed two inter-related risk factors for colon cancer (obesity and abnormal gut bacterial microbiome) and their genetic associations within this population. To evaluate potential unique characteristics of the high-incidence cohort, we compared 99 propensity-matched colon cancer tumors from Appalachian Kentucky patients to 95 non-Appalachian patient tumors to evaluate driver mutations, differentially expressed genes (DEGs), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, Catalogue of Somatic Mutations in Cancer (COSMIC) mutational signatures, immune cell populations, and microbiomes in an obesity context. Our comparison identified significant population-specific DEGs and differences in COSMIC signature frequencies, KEGG pathway regulation, pro-carcinogenic immune cell features, microbiome species, and obesity-associated inflammatory and metabolic responses between the cohorts. The findings offer generalizable implications deriving from Appalachian Kentuckians while highlighting the critical importance of population-based studies in colon cancer research.